Alector, Inc. (ALEC): Depreciation & Amortization
$5.72M
Year ended 2025-12-31
$4.54M
Trailing 12 months to 2026-06-30
0.0%
3-year compound annual growth
-0.5%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.72M | +5.8% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $5.41M | -5.6% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $5.72M | +0.2% | 2025-02-26, From 2023-01-01 |
| 2022-12-31 | $5.71M | -9.7% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $6.33M | +7.8% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $5.87M | +55.5% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $3.77M | +270.5% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $1.02M | +49.9% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $680.0K | n/a | 2020-03-24, From 2017-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Alector, Inc. (ALEC) | 2025-12-31 | $5.72M | +5.8% |
| LENZ Therapeutics, Inc. (LENZ) | 2025-12-31 | $287.0K | +394.8% |
| Scilex Holding Co (SCLX) | 2025-12-31 | $4.62M | +14.3% |
| Lineage Cell Therapeutics, Inc. (LCTX) | 2025-12-31 | $699.0K | +19.1% |
| Precision Biosciences Inc (DTIL) | 2025-12-31 | $1.47M | -56.9% |
| X4 Pharmaceuticals, Inc (XFOR) | 2025-12-31 | $1.28M | +60.4% |
| C4 Therapeutics, Inc. (CCCC) | 2025-12-31 | $1.96M | +7.8% |
| Kymera Therapeutics, Inc. (KYMR) | 2025-12-31 | $8.31M | +12.7% |
| Sangamo Therapeutics, Inc (SGMOQ) | 2025-12-31 | $3.96M | -22.4% |
Compare ALEC, LENZ, SCLX, LCTX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗